Literature DB >> 21378024

Depletion of tissue plasminogen activator attenuates lung ischemia-reperfusion injury via inhibition of neutrophil extravasation.

Yunge Zhao1, Ashish K Sharma, Damien J LaPar, Irving L Kron, Gorav Ailawadi, Yuan Liu, David R Jones, Victor E Laubach, Christine L Lau.   

Abstract

Ischemia-reperfusion (IR) injury following lung transplantation remains a major source of early morbidity and mortality. Histologically, this inflammatory process is characterized by neutrophil infiltration and activation. We previously reported that lung IR injury was significantly attenuated in plasminogen activator inhibitor-1-deficient mice. In this study, we explored the potential role of tissue plasminogen activator (tPA) in a mouse lung IR injury model. As a result, tPA knockout (KO) mice were significantly protected from lung IR injury through several mechanisms. At the cellular level, tPA KO specifically blocked neutrophil extravasation into the interstitium, and abundant homotypic neutrophil aggregation (HNA) was detected in the lung microvasculature of tPA KO mice after IR. At the molecular level, inhibition of neutrophil extravasation was associated with reduced expression of platelet endothelial cell adhesion molecule-1 mediated through the tPA/ LDL receptor-related protein/NF-κB signaling pathway, whereas increased P-selectin triggered HNA. At the functional level, tPA KO mice incurred significantly decreased vascular permeability and improved lung function following IR. Protection from lung IR injury in tPA KO mice occurs through a fibrinolysis-independent mechanism. These results suggest that tPA could serve as an important therapeutic target for the prevention and treatment of acute IR injury after lung transplantation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21378024      PMCID: PMC3094027          DOI: 10.1152/ajplung.00227.2010

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  38 in total

1.  In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA.

Authors:  S R Schwarze; S F Dowdy
Journal:  Trends Pharmacol Sci       Date:  2000-02       Impact factor: 14.819

Review 2.  Matrix metalloproteinase-9 expression after myocardial infarction: physiological or pathological?

Authors:  Matt M Thompson; Iain B Squire
Journal:  Cardiovasc Res       Date:  2002-06       Impact factor: 10.787

Review 3.  The role of neutrophils in myocardial ischemia-reperfusion injury.

Authors:  J E Jordan; Z Q Zhao; J Vinten-Johansen
Journal:  Cardiovasc Res       Date:  1999-09       Impact factor: 10.787

4.  Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.

Authors:  Yun-Ge Zhao; Ai-Zhen Xiao; Robert G Newcomer; Hyun I Park; Tiebang Kang; Leland W K Chung; Mark G Swanson; Haiyen E Zhau; John Kurhanewicz; Qing-Xiang Amy Sang
Journal:  J Biol Chem       Date:  2003-02-13       Impact factor: 5.157

5.  Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

Authors:  M Asahi; K Asahi; J C Jung; G J del Zoppo; M E Fini; E H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2000-12       Impact factor: 6.200

6.  Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion.

Authors:  M Lindsey; K Wedin; M D Brown; C Keller; A J Evans; J Smolen; A R Burns; R D Rossen; L Michael; M Entman
Journal:  Circulation       Date:  2001-05-01       Impact factor: 29.690

7.  An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9.

Authors:  Yunge Zhao; Aizhen Xiao; Charles G diPierro; Joan E Carpenter; Rana Abdel-Fattah; Gerard T Redpath; Maria-Beatriz S Lopes; Isa M Hussaini
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

8.  Clinical risk factors for primary graft failure following lung transplantation.

Authors:  Jason D Christie; Robert M Kotloff; Alberto Pochettino; Selim M Arcasoy; Bruce R Rosengard; J Richard Landis; Stephen E Kimmel
Journal:  Chest       Date:  2003-10       Impact factor: 9.410

9.  Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.

Authors:  Xiaoying Wang; Sun-Ryung Lee; Ken Arai; Seong-Ryong Lee; Kiyoshi Tsuji; G William Rebeck; Eng H Lo
Journal:  Nat Med       Date:  2003-09-07       Impact factor: 53.440

Review 10.  Science review: Cell membrane expression (connectivity) regulates neutrophil delivery, function and clearance.

Authors:  Andrew J E Seely; José L Pascual; Nicolas V Christou
Journal:  Crit Care       Date:  2003-01-09       Impact factor: 9.097

View more
  9 in total

1.  Prevention of the second stage of epithelial loss is a potential novel treatment for bronchiolitis obliterans.

Authors:  Yunge Zhao; John F Steidle; Gilbert R Upchurch; Irving L Kron; Christine L Lau
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-28       Impact factor: 5.209

2.  Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model.

Authors:  Yunge Zhao; Jacob R Gillen; David A Harris; Irving L Kron; Michael P Murphy; Christine L Lau
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-04       Impact factor: 5.209

3.  Adenosine A1 receptor activation attenuates lung ischemia-reperfusion injury.

Authors:  Lucas G Fernandez; Ashish K Sharma; Damien J LaPar; Irving L Kron; Victor E Laubach
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-08       Impact factor: 5.209

4.  Intermittent Hypoxia Activates Duration-Dependent Protective and Injurious Mechanisms in Mouse Lung Endothelial Cells.

Authors:  Peter Wohlrab; Lourdes Soto-Gonzales; Thomas Benesch; Max Paul Winter; Irene Marthe Lang; Klaus Markstaller; Verena Tretter; Klaus Ulrich Klein
Journal:  Front Physiol       Date:  2018-12-06       Impact factor: 4.566

5.  Nebulized fibrinolytic agents improve pulmonary fibrinolysis but not inflammation in rat models of direct and indirect acute lung injury.

Authors:  Jorrit J Hofstra; Alexander D Cornet; Paul J Declerck; Barry Dixon; Hamid Aslami; Alexander P J Vlaar; Joris J Roelofs; Tom van der Poll; Marcel Levi; Marcus J Schultz
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

6.  Astragalus Polysaccharide Suppresses the Expression of Adhesion Molecules through the Regulation of the p38 MAPK Signaling Pathway in Human Cardiac Microvascular Endothelial Cells after Ischemia-Reperfusion Injury.

Authors:  Zhu Hai-Yan; Gao Yong-Hong; Wang Zhi-Yao; Xu Bing; Wu Ai-Ming; Xing Yan-Wei; Liu Bei; Lou Li-Xia; Chen Li-Xin
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-05       Impact factor: 2.629

7.  Total Body Irradiation Mitigates Inflammation and Extends the Therapeutic Time Window for Anti-Ricin Antibody Treatment against Pulmonary Ricinosis in Mice.

Authors:  Yoav Gal; Anita Sapoznikov; Reut Falach; Sharon Ehrlich; Moshe Aftalion; Chanoch Kronman; Tamar Sabo
Journal:  Toxins (Basel)       Date:  2017-09-11       Impact factor: 4.546

8.  Increased mortality in elderly patients with acute respiratory distress syndrome is not explained by host response.

Authors:  Laura R A Schouten; Lieuwe D J Bos; A Serpa Neto; Lonneke A van Vught; Maryse A Wiewel; Arie J Hoogendijk; Marc J M Bonten; Olaf L Cremer; Janneke Horn; Tom van der Poll; Marcus J Schultz; Roelie M Wösten-van Asperen
Journal:  Intensive Care Med Exp       Date:  2019-10-29

9.  Recombinant Tissue Plasminogen Activator (r-tPA) Induces In-Vitro Human Neutrophil Migration via Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1).

Authors:  Luca Liberale; Maria Bertolotto; Silvia Minetti; Paola Contini; Daniela Verzola; Pietro Ameri; Giorgio Ghigliotti; Aldo Pende; Giovanni G Camici; Federico Carbone; Fabrizio Montecucco
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.